Biomedical Engineering Reference
In-Depth Information
by angiopoietins and VEGF. Oncogene 18:5356-
5362.
88. Holzer G, Majeska RJ, Lundy MW, Hartke JR, Einhorn
TA (1999) Parathyroid hormone enhances fracture
healing. Clin Orthop 366:258-263.
89. Horner A, Bord S, Kelsall AW, Coleman N, Compston
JE (2001) Tie2 ligands angiopoietin-1 and angiopoi-
etin-2 are coexpressed with vascular endothelial cell
growth factor in growing human bone. Bone 28:65-
71.
90. Hunziker EB, Schenk RK, Cruz-Orive LM (1987)
Quantitation of chondrocyte performance in growth-
plate cartilage during longitudinal bone growth. J
Bone Joint Surg Am 69:162-173.
91. Ikeya M, Takada S (2001) Wnt-3a is required for
somite specifi cation along the anteroposterior axis of
the mouse embryo and for regulation of cdx-1 expres-
sion. Mech Dev 103:27-33.
92. Iwata H, Sakano S, Itoh T, Bauer TW (2002) Demin-
eralized bone matrix and native bone morphogenetic
protein in orthopaedic surgery. Clin Orthop
395:99-109.
93. Jabs EW, Li X, Scott AF, Meyers G, Chen W, Eccles M,
Mao JI, Charnas LR, Jackson CE, Jaye M (1994)
Jackson-Weiss and Crouzon syndromes are allelic
with mutations in fi broblast growth factor receptor
2. Nat Genet 8:275-279.
94. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP
(1997) Osteogenic differentiation of purifi ed, culture-
expanded human mesenchymal stem cells in vitro.
J Cell Biochem 64:295-312.
95. Jansen M (1934) Über atypische Chondrodystophie
(Achondroplasie) und über eine noch nicht bes-
chriebene angeborene Wachstumsstörung des Kno-
chensystems: Metaphysäre Dysostosis. Zeitschr
Orthop Chir 61:253-286.
96. Jingushi S, Urabe K, Okazaki K, Hirata G, Sakai A,
Ikenoue T, Iwamoto Y (2002) Intramuscular bone
induction by human recombinant bone morphoge-
netic protein-2 with beta-tricalcium phosphate as a
carrier: in vivo bone banking for muscle-pedicle
autograft. J Orthop Sci 7:490-494.
97. Jobert AS, Zhang P, Couvineau A, Bonaventure J,
Roume J, Le Merrer M, Silve C (1998) Absence of
functional receptors for parathyroid hormone and
parathyroid hormone-related peptide in Blomstrand
chondrodysplasia. J Clin Invest 102:34-40.
98. Jones PF (2003) Not just angiogenesis—wider roles
for the angiopoietins. J Pathol 201:515-527.
99. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M,
Sherr DH, Stanger BZ, Marshak-Rothstein A (1995)
Fas (CD95)/FasL interactions required for pro-
grammed cell death after T-cell activation. Nature
373:444-448.
100. Kaku M, Kohno S, Kawata T, Fujita I, Tokimasa C,
Tsutsui K, Tanne K (2001) Effects of vascular
endothelial growth factor on osteoclast induction
during tooth movement in mice. J Dent Res 80:1880-
1883.
101. Kanzler B, Foreman RK, Labosky PA, Mallo M (2000)
BMP signaling is essential for development of skele-
togenic and neurogenic cranial neural crest. Devel-
opment 127:1095-1104.
102. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybule-
wicz VL, Kronenberg HM, Mulligan RC (1994) Lethal
skeletal dysplasia from targeted disruption of para-
thyroid hormone-related peptide gene. Genes Dev
8:277-289.
103. Karp SJ, Schipani E, St-Jacques B, Hunzelman J, Kro-
nenberg H, McMahon AP (2000) Indian hedgehog
coordinates endochondral bone growth and mor-
phogenesis via parathyroid hormone related-protein-
dependent and -independent pathways. Development
127:543-548.
104. Katagiri T, Yamaguchi A, Komaki M, Abe E, Taka-
hashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-
Sehara A, Suda T (1994) Bone morphogenetic
protein-2 converts the differentiation pathway of
C2C12 myoblasts into the osteoblast lineage. J Cell
Biol 127:1755-1766.
105. Katavic V, Lukic IK, Kovacic N, Grcevic D, Lorenzo
JA, Marusic A (2003) Increased bone mass is a
part of the generalized lymphoproliferative disorder
phenotype in the mouse. J Immunol 170:1540-
1547.
106. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH,
Glass DA 2nd, Hartmann C, Li L, Hwang TH, Brayton
CF, Lang RA, Karsenty G, Chan L (2002) Cbfa1-inde-
pendent decrease in osteoblast proliferation, osteo-
penia, and persistent embryonic eye vascularization
in mice defi cient in Lrp5, a Wnt coreceptor. J Cell Biol
157:303-314.
107. Kawabata M, Imamura T, Miyazono K (1998) Signal
transduction by bone morphogenetic proteins. Cyto-
kine Growth Factor Rev 9:49-61.
108. Kawakami Y, Capdevila J, Buscher D, Itoh T,
Rodriguez Esteban C, Izpisua Belmonte JC (2001)
WNT signals control FGF-dependent limb initiation
and AER induction in the chick embryo. Cell
104:891-900.
109. Kawakami Y, Wada N, Nishimatsu SI, Ishikawa T,
Noji S, Nohno T (1999) Involvement of Wnt-5a in
chondrogenic pattern formation in the chick limb
bud. Dev Growth Differ 41:29-40.
110. Kengaku M, Capdevila J, Rodriguez-Esteban C, De La
Pena J, Johnson RL, Belmonte JC, Tabin CJ (1998)
Distinct WNT pathways regulating AER formation
and dorsoventral polarity in the chick limb bud.
Science 280:1274-1277.
111. Kiener PA, Davis PM, Starling GC, Mehlin C, Kle-
banoff SJ, Ledbetter JA, Liles WC (1997) Differential
induction of apoptosis by Fas-Fas ligand interactions
in human monocytes and macrophages. J Exp Med
185:1511-1516.
112. Kim HW, Jahng JS (1999) Effect of intermittent
administration of parathyroid hormone on fracture
healing in ovariectomized rats. Iowa Orthop J
19:71-77.
113. Kim KS, Tinti C, Song B, Cubells JF, Joh TH (1994)
Cyclic AMP-dependent protein kinase regulates
basal and cyclic AMP-stimulated but not phorbol
ester-stimulated transcription of the tyrosine
hydroxylase gene. J Neurochem 63:834-842.
114. Kim N, Odgren PR, Kim DK, Marks SC Jr, Choi Y
(2000) Diverse roles of the tumor necrosis factor
family member TRANCE in skeletal physiology
revealed by TRANCE defi ciency and partial rescue
by a lymphocyte-expressed TRANCE transgene.
Proc Natl Acad Sci USA 97:10905-10910.
115. Kimble RB, Bain S, Pacifi ci R (1997) The functional
block of TNF but not IL-6 prevents bone loss i n ova ri-
ectomized mice. J Bone Miner Res 12:935-941.
